- Home
- STRO vs AFRI Comparison
STRO vs AFRI Comparison
Compare STRO & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STRO | AFRI |
|---|---|---|
| Founded | 2003 | 1943 |
| Country | United States | Gibraltar |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.8M | 269.1M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | STRO | AFRI |
|---|---|---|
| Price | $16.69 | $11.05 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $31.33 | N/A |
| AVG Volume (30 Days) | ★ 263.7K | 16.0K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $38,419,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $8.13 |
| 52 Week High | $43.85 | $11.90 |
Technical Indicators
Market Signals| Indicator | STRO | AFRI |
|---|---|---|
| Relative Strength Index (RSI) | 27.91 | 59.93 |
| Support Level | $10.34 | $9.54 |
| Resistance Level | $26.35 | $11.83 |
| Average True Range (ATR) | 1.05 | 0.50 |
| MACD | -0.14 | 0.02 |
| Stochastic Oscillator | 4.21 | 60.31 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in the production and sale of wheat flour, semolina, pasta, and couscous products. The company operates through the Soft Wheat, Durum Wheat, and Couscous & Pasta segments. Its main brands include MAYMOUNA and TRIA. It generates the majority of its revenue from the Soft Wheat segment.